Comparison of four prognostic scores in peripheral T-cell lymphoma

被引:82
作者
Gutierrez-Garcia, G. [1 ]
Garcia-Herrera, A. [2 ]
Cardesa, T. [2 ]
Martinez, A. [2 ]
Villamor, N. [2 ]
Ghita, G. [1 ]
Martinez-Trillos, A. [1 ]
Colomo, L. [2 ]
Setoain, X. [3 ]
Rodriguez, S. [4 ]
Gine, E. [1 ]
Campo, E. [2 ]
Lopez-Guillermo, A. [1 ]
机构
[1] Hosp Clin Barcelona, Dept Hematol, Inst Recerca Biomed August Pi & Sunyer, E-08036 Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Pathol, Inst Recerca Biomed August Pi & Sunyer, E-08036 Barcelona, Spain
[3] Hosp Clin Barcelona, Dept Nucl Med, Inst Recerca Biomed August Pi & Sunyer, E-08036 Barcelona, Spain
[4] Hosp Clin Barcelona, Dept Radiol, Inst Recerca Biomed August Pi & Sunyer, E-08036 Barcelona, Spain
关键词
peripheral T-cell lymphoma; prognostic score; outcome; NON-HODGKINS-LYMPHOMAS; DETUDE-DES-LYMPHOMES; MOLECULAR SIGNATURES; REAL CLASSIFICATION; ELDERLY-PATIENTS; SINGLE-CENTER; TRANSPLANTATION; EXPRESSION; FEATURES; PROJECT;
D O I
10.1093/annonc/mdq359
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To compare the usefulness of four prognostic scores in patients with peripheral T-cell lymphoma (PTCL) from a single institution. Patients and methods: One hundred twenty-one patients (77 male/36 female, median age 53 years) with PTCL [ anaplastic large-cell lymphoma (ALCL) 21, PTCL not otherwise specified 56 and other 44)]. Complete response (CR) rate and 5-year overall survival (OS) were 41% and 31%, respectively. International Prognostic Index (IPI), Prognostic Index for T-cell lymphoma (PIT), International peripheral T-cell lymphoma Project score (IPTCLP) and modified Prognostic Index for T-cell lymphoma (mPIT) were calculated as in the original references. mPIT was only assembled to 41 patients in whom Ki-67 immunostaining was available. ALCL patients were analyzed separately. Results: Concordance among IPI, PIT and IPTCLP was 52% for low-risk group, 27% for low/intermediate-risk group, 20% for high/intermediate-risk group and 14% for high-risk group. IPI, PIT and IPTCLP predicted CR, with IPI being the best score in logistic regression. Neither Ki-67 immunostaining nor mPIT predicted CR. Five-year OS (low-risk versus intermediate- or high-risk categories) according to IPI, PIT, IPTCLP and mPIT were 52% versus 45%, 75% versus 49%, 58% versus 20% and 39% versus 0%, respectively. IPTCLP was the best score for OS in multivariate analysis. Conclusion: All the scores demonstrated their usefulness to assess the outcome of patients with PTCL, with IPTCLP being the most significant to predict OS.
引用
收藏
页码:397 / 404
页数:8
相关论文
共 42 条
[1]   Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies [J].
Agostinelli, C. ;
Piccaluga, P. P. ;
Went, P. ;
Rossi, M. ;
Gazzola, A. ;
Righi, S. ;
Sista, T. ;
Campidelli, C. ;
Zinzani, P. L. ;
Falini, B. ;
Pileri, S. A. .
JOURNAL OF CLINICAL PATHOLOGY, 2008, 61 (11) :1160-1167
[2]   Epidemiology of the non-Hodgkin's lymphomas: Distributions of the major subtypes differ by geographic locations [J].
Anderson, JR ;
Armitage, JO ;
Weisenburger, DD .
ANNALS OF ONCOLOGY, 1998, 9 (07) :717-720
[3]   Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the REAL classification [J].
Ascani, S ;
Zinzani, PL ;
Gherlinzoni, F ;
Sabattini, E ;
Briskomatis, A ;
deVivo, A ;
Piccioli, M ;
Orcioni, GF ;
Pieri, F ;
Goldoni, A ;
Piccaluga, PP ;
Zallocco, D ;
Burrelli, R ;
Leoncini, L ;
Falini, B ;
Tura, S ;
Pileri, SA .
ANNALS OF ONCOLOGY, 1997, 8 (06) :583-592
[4]   Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years [J].
Au, WY ;
Ma, SY ;
Chim, CS ;
Choy, C ;
Loong, F ;
Lie, AKW ;
Lam, CCK ;
Leung, AYH ;
Tse, E ;
Yau, CC ;
Liang, R ;
Kwong, YL .
ANNALS OF ONCOLOGY, 2005, 16 (02) :206-214
[5]   Angiocentric nasal T/natural killer cell lymphoma:: a single centre study of prognostic factors in 108 patients [J].
Avilés, A ;
Díaz, NR ;
Neri, N ;
Cleto, S ;
Talavera, A .
CLINICAL AND LABORATORY HAEMATOLOGY, 2000, 22 (04) :215-220
[6]   Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas [J].
Ballester, B ;
Ramuz, O ;
Gisselbrecht, C ;
Doucet, G ;
Loï, L ;
Loriod, B ;
Bertucci, F ;
Bouabdallah, R ;
Devilard, E ;
Carbuccia, N ;
Mozziconacci, MJ ;
Birnbaum, D ;
Brousset, P ;
Berger, F ;
Salles, G ;
Briére, J ;
Houlgatte, R ;
Gaulard, P ;
Xerri, L .
ONCOGENE, 2006, 25 (10) :1560-1570
[7]   Revised response criteria for malignant lymphoma [J].
Cheson, Bruce D. ;
Pfistner, Beate ;
Juweid, Malik E. ;
Gascoyne, Randy D. ;
Specht, Lena ;
Horning, Sandra J. ;
Coiffier, Bertrand ;
Fisher, Richard I. ;
Hagenbeek, Anton ;
Zucca, Emanuele ;
Rosen, Steven T. ;
Stroobants, Sigrid ;
Lister, T. Andrew ;
Hoppe, Richard T. ;
Dreyling, Martin ;
Tobinai, Kensei ;
Vose, Julie M. ;
Connors, Joseph M. ;
Federico, Massimo ;
Diehl, Volker .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :579-586
[8]   State-of-the-art therapeutics: Diffuse large B-cell lymphoma [J].
Coiffier, B .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (26) :6387-6393
[9]   Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation [J].
Corradini, P. ;
Tarella, C. ;
Zallio, F. ;
Dodero, A. ;
Zanni, M. ;
Valagussa, P. ;
Gianni, A. M. ;
Rambaldi, A. ;
Barbui, T. ;
Cortelazzo, S. .
LEUKEMIA, 2006, 20 (09) :1533-1538
[10]  
COX DR, 1972, J R STAT SOC B, V34, P187